IDEXX Laboratories, Inc.IDXX
NasdaqGS•Healthcare•Diagnostics & Research
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $4.45B, growing 13.1% year-over-year. TTM net income stood at $1.10B (22.4% growth). Quarterly EBITDA was $400.27M and operating income was $362.59M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze IDXX growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters